Original title: Comparative Diagnostic Sensitivity of Endoscopic Ultrasound-guided Tissue Acquisition for Hepatocellular Carcinoma Versus Intrahepatic Cholangiocarcinoma
Yuichi Takano, Naoki Tamai, Jun Noda, Tetsushi Azami +8 · August 2026
Doctors need to tell two types of liver cancer apart to choose the right treatment. One is hepatocellular carcinoma, and the other is intrahepatic cholangiocarcinoma. To check, doctors use endoscopic ultrasound-guided tissue acquisition. They pass a thin, flexible tube with an ultrasound camera inside the body to guide a needle into liver spots and collect tissue samples. Researchers reviewed past records to compare how well this sampling method spots both cancers. They found that it worked well for both, but it was less sensitive for hepatocellular carcinoma than for intrahepatic cholangiocarcinoma. The test caught intrahepatic cholangiocarcinoma in every case, but it missed some cases of hepatocellular carcinoma. This drop in sensitivityThe chance that a test correctly finds the disease when it is actually there. was even bigger when looking only at loose cells under a microscope rather than intact tissue pieces. Finally, the procedure was safe, causing no procedure-related adverse events in any of the patients.
Imagine you are at a potluck and want to identify what is in each dish before serving yourself. With one dish, a single small taste tells you exactly what it is. With another, every spoonful you manage to grab is mostly sauce, so even after several tries you still cannot name the main ingredient. In this paper, the spoon is the sampling needle and the liver growth is the dish. One cancer type gives a clean, readable sample almost every time; the other often yields so little useful tissue that the diagnosis has to lean on a larger sample.
Two liver cancers — hepatocellular carcinoma and intrahepatic cholangiocarcinoma — require different treatments, so telling them apart changes what a patient goes through. This study shows the needle test is safe and usually reliable, but for one of the two cancers the cell sample alone frequently fails. That tells doctors to push for a tissue core when they suspect that cancer, so patients get the right treatment the first time.
The abstract doesn't say how the final diagnosis was confirmed, and it doesn't compare EUS-TA against other sampling methods. What it does state: single-center retrospective design, only 45 patients, wide confidence intervals, and fewer fine-needle biopsy needles used in the HCC group — an imbalance that could partly explain the lower sensitivity.
Ask anything about this paper. Answers come from its abstract, and say so when the abstract doesn't cover your question.
Comparative Diagnostic Sensitivity of Endoscopic Ultrasound-guided Tissue Acquisition for Hepatocellular Carcinoma Versus Intrahepatic Cholangiocarcinoma — Yuichi Takano, Naoki Tamai, Jun Noda et al. — DEN open — doi:10.1002/deo2.70423
Abstract licence: CC BY
Explanation generated by Synthesis from the abstract — it is not the original paper.